Patent details

Basic Information

Publication number:

EP2116259

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP091689703

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TACI-immunoglobulin fusion proteins

French Title of Invention:

Protéines de fusion d'immunoglobuline-TACI

German Title of Invention:

TACI-Immunoglobulin-Fusionsproteine

SPC Number:

Dates

Filing date:

20/05/2002

Grant date:

25/01/2012

EP Publication Date:

25/01/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/11/2009

EP B1 Publication Date:

25/01/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/05/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/05/2002

 

 

Name:

ZymoGenetics Inc.

Address:

1201 Eastlake Avenue East, Seattle, Washington 98102, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

21/03/2012

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Gross Jane A

Address:

United States (US)

2

Name:

Rixon Mark W

Address:

United States (US)

Priority

Priority Number:

293343 P

Priority Date:

24/05/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/05/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56